Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10319577 | 0.74 | TSHR (0.48) | DPP4TSHRF2HTR2ATAAR1 | |
| SCHEMBL15798275 | 0.69 | KMT2A (0.37) | DPP4TSHRF2HTR2ACYP2D6 | |
| SCHEMBL1325645 | 0.69 | TDP1 (0.36) | TSHRHTR2ATAAR1CYP2D6LMNA | |
| SCHEMBL827249 | 0.69 | ALDH1A1 (0.30) | — | |
| SCHEMBL5614009 | 0.69 | ALDH1A1 (0.30) | — | |
| SCHEMBL2686473 | 0.69 | TSHR (0.48) | DPP4TSHRF2HTR2ATAAR1 | |
| SCHEMBL3894050 | 0.69 | TSHR (0.44) | DPP4TSHRF2CYP2D6SRC | |
| SCHEMBL12815293 | 0.65 | TSHR (0.38) | TSHRTAAR1CYP2D6LMNASLC6A2 | |
| SCHEMBL15302723 | 0.65 | TAAR1 (0.33) | TSHRHTR2ATAAR1CYP2D6LMNA | |
| SCHEMBL15302680 | 0.65 | TDP1 (0.33) | TSHRTAAR1CYP2D6LMNASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8217060-B2 | Benzimidazole derivatives useful as TRP M8 receptor modulators | JANSSEN PHARMACEUTICA, NV (BE) | 2012-07-10 | — | — | US | claimed |
| US-20100292276-A1 | BENZIMIDAZOLE DERIVATIVES USEFUL AS TRP M8 RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA, NV (BE) | 2010-11-18 | — | — | US | claimed |
| US-20230253626-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-08-10 | — | — | US | disclosed |
| US-20230051031-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON SEPIOLITE FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2023-02-16 | — | — | US | disclosed |
| US-20230034883-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON NATURAL CLAYS FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (60%) (IT) | 2023-02-02 | — | — | US | disclosed |
| EP-4076730-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON SEPIOLITE FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | Consiglio Nazionale Delle Ricerche (IT) | 2022-10-26 | — | — | EP | disclosed |
| EP-4076729-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON NATURAL CLAYS FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | Consiglio Nazionale Delle Ricerche (IT) | 2022-10-26 | — | — | EP | disclosed |
| WO-2021124097-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON SEPIOLITE FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021124103-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON NATURAL CLAYS FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2021-06-24 | — | — | WO | disclosed |
| US-9926383-B2 | Biocompatible three dimensional matrix for the immobilization of biological substances | LEUKOCARE AG (DE) | 2018-03-27 | — | — | US | disclosed |
| US-9206202-B2 | Carbazole derivative and semiconductor nanocrystal | RICOH COMPANY, LTD. (JP) | 2015-12-08 | — | — | US | disclosed |
| US-20090269778-A1 | BIOCOMPATIBLE THREE DIMENSIONAL MATRIX FOR THE IMMOBILIZATION OF BIOLOGICAL SUBSTANCES | LEUKOCARE AG (DE) | 2009-10-29 | — | — | US | disclosed |
| WO-2009059784-A1 | BIOCOMPATIBLE THREE DIMENSIONAL MATRIX FOR THE IMMOBILIZATION OF BIOLOGICAL SUBSTANCES | LEUKOCARE AG (DE) | 2009-05-14 | — | — | WO | disclosed |
| EP-2058335-A1 | Biocompatible three dimensional matrix for the immobilization of biological substances | Leukocare AG (DE) | 2009-05-13 | — | — | EP | disclosed |
| US-20090118222-A1 | NOVEL PYRIMIDINE NUCLEOSIDE COMPOUND OR ITS SALT | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2009-05-07 | — | — | US | disclosed |
| EP-2045258-A1 | 3'-ETHYNYLCYTIDINE DERIVATIVE | Taiho Pharmaceutical Co., Ltd. (JP) | 2009-04-08 | — | — | EP | disclosed |
| EP-2021374-A1 | BIOCOMPATIBLE THREE DIMENSIONAL MATRIX FOR THE IMMOBILIZATION OF BIOLOGICAL SUBSTANCES | Leukocare AG (DE) | 2009-02-11 | — | — | EP | disclosed |
| WO-2007128550-A1 | BIOCOMPATIBLE THREE DIMENSIONAL MATRIX FOR THE IMMOBILIZATION OF BIOLOGICAL SUBSTANCES | LEUKOCARE AG (DE) | 2007-11-15 | — | — | WO | disclosed |
| EP-1852443-A1 | Biocompatible three dimensional matrix for the immobilization of biological substances | Leukocare AG (DE) | 2007-11-07 | — | — | EP | disclosed |
| EP-1845102-A1 | NOVEL PYRIMIDINE NUCLEOSIDE COMPOUND OR ITS SALT | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118222-A1 | NOVEL PYRIMIDINE NUCLEOSIDE COMPOUND OR ITS SALT | CDK10, SRSF9, SNRPD1 | DPP4 3389/4885TSHR 2261/4885F2 3366/4885 |
| US-20100292276-A1 | BENZIMIDAZOLE DERIVATIVES USEFUL AS TRP M8 RECEPTOR MODULATORS | TRPM8, TRPV1, TRPA1 | DPP4 575/4885TSHR 2835/4885F2 4506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.